CORDIS - EU research results
CORDIS

Profiling the emergence of phenotypic heterogeneity in breast cancer organoids

Project description

Delineating tumour heterogeneity using organoids

Accumulating evidence suggests that cellular heterogeneity supports tumour growth and induces resistance to therapy. However, we lack fundamental information on its spatiotemporal emergence. To address this issue, the EU-funded SpatialOrganoids project will undertake experimental and computational analyses of breast cancer 3D organoid cultures over time. By capturing spatiotemporal changes in cellular phenotypes, scientists will identify molecular and spatial determinants of breast cancer heterogeneity. Given the high incidence of breast cancer in women and the extensive intra- and inter-patient heterogeneity, the project's results will contribute to the development of new targeted treatment strategies.

Objective

Cell-to-cell heterogeneity in biological systems has been broadly studied in unicellular organisms and mammals. Furthermore, non-genetic, in addition to genetic heterogeneity has been recently proposed to support tumour growth and to induce resistance to cancer therapy. However, the molecular events on a spatial and temporal level that lead to the emergence of tumour heterogeneity are largely unknown. To address this question, I will study breast cancer, which shows the highest cancer incidence in women and is characterised by extensive intra- and inter-patient heterogeneity in cellular and molecular phenotypes. As model system, I select 3D organoid cultures, which are gaining popularity in cancer research due to their ability to reconstruct tumour-like molecular features and to recapitulate treatment response.
Here, I propose experimental and computational time-course analyses of breast cancer organoids to understand molecular and spatial determinants that underlie the emergence of heterogeneity in cancer cell phenotypes. On the experimental side, I will use imaging mass cytometry and perturbation experiments to capture and validate spatio-temporal changes in cellular phenotypes, interactions and signalling networks. Statistical modelling will quantify dynamic changes in phenotypic heterogeneity over the time-course of organoid growth. Finally, I will predict the emergence of intra-organoid heterogeneity across multiple organoid lines, which allows me to derive targeted treatment strategies.
In sum, the proposed work will disentangle and perturb the spatio-temporal emergence of phenotypic intra-tumour heterogeneity, which is characteristic of breast cancer tissues.

Coordinator

UNIVERSITAT ZURICH
Net EU contribution
€ 191 149,44
Address
RAMISTRASSE 71
8006 Zurich
Switzerland

See on map

Region
Schweiz/Suisse/Svizzera Zürich Zürich
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 191 149,44